(A) Pharmacies pursuant to paragraphs (A)
and (B) of rule 4729:8-3-01 of the Administrative Code that dispense drugs
listed in Chapter 4729:8-2 of the Administrative Code to outpatients shall
report the following dispensing information to the board of pharmacy in
accordance with rule 4729:8-3-03 of the Administrative Code:
(1) Pharmacy drug
enforcement administration registration number. If not applicable, another
mutually acceptable identifier;
(2) Pharmacy
name;
(3) Pharmacy
address;
(4) Pharmacy telephone
number;
(5) Patient full
name;
(6) Patient residential
address;
(7) Patient telephone
number;
(8) Patient date of
birth;
(9) Patient
gender;
(10) Prescriber's
full name (first name and last name);
(11) Prescriber's
drug enforcement administration registration number. If not applicable, another
mutually acceptable identifier;
(12) Date prescription
was issued by the prescriber;
(13) Date the
prescription was dispensed or sold by the pharmacy;
(14) Indication of
whether the prescription dispensed is new or a refill;
(15) Number of the refill
being dispensed;
(16) National drug code
of the drug dispensed;
(17) Quantity of the drug
prescribed;
(18) Quantity of drug
dispensed;
(19) Number of days'
supply of the drug dispensed as indicated by the prescriber pursuant to agency
4729 of the Administrative Code, except as follows:
(a) If a days' supply is not indicated by the
prescriber, the pharmacy shall calculate and report the number of days'
supply of the drug dispensed;
(b) If the quantity of drug dispensed is different from the
quantity indicated on the prescription, the pharmacy shall calculate and report
the number of days' supply of the drug dispensed.
(20) Serial or
prescription number assigned to the prescription order;
(21) Source of payment
for the prescription that indicates one of the following: private pay (cash),
medicaid, medicare, commercial insurance, or workers'
compensation;
(22) Pharmacy national
provider identification (NPI) number;
(23) Prescriber's
national provider identification (NPI) number, if prescriber does not have an
NPI, then another mutually acceptable identifier;
(24) Any of the following
as indicated by the prescriber pursuant to agency 4729 of the Administrative
Code:
(a) The ICD-10-CM medical diagnosis code of the primary
disease or condition that the controlled substance drug is being used to treat.
The code shall, at a minimum, include the first four alpha-numeric characters
of the ICD-10-CM medical diagnosis code, sometimes referred to as the category
and the etiology (ex. M 16.5);
(b) For dentists licensed pursuant to Chapter 4715. of the
Revised Code, the "Code on Dental Procedures and Nomenclature" (CDT
code), as published by the American dental association, of the dental treatment
requiring the controlled substance prescription;
(c) If no such code is indicated on the prescription, the
pharmacy shall indicate "NC" in the diagnosis data
field.
(B) Prescribers pursuant to paragraph (E)
of rule 4729:8-3-01 of the Administrative Code that personally furnish drugs
listed in Chapter 4729:8-2 of the Administrative Code shall report the
following information to the board of pharmacy in accordance with rule
4729:8-3-03 of the Administrative Code:
(1) Prescriber drug
enforcement administration registration number. If not applicable, another
mutually acceptable identifier;
(2) Prescriber full name
(first and last name);
(3) Prescriber
address;
(4) Prescriber telephone
number;
(5) Patient full
name;
(6) Patient residential
address;
(7) Patient telephone
number;
(8) Patient date of
birth;
(9) Patient
gender;
(10) Date the drug was
personally furnished by the prescriber;
(11) National drug code
of the drug personally furnished;
(12) Quantity of drug
personally furnished;
(13) Number of intended
days' supply of drug personally furnished;
(14) Source of payment
for the prescription that indicates one of the following: private pay (cash),
medicaid, medicare, commercial insurance, or workers'
compensation;
(15) Either of the
following:
(a) The ICD-10-CM medical diagnosis code of the primary
disease or condition that the controlled substance drug is being used to treat.
The code shall, at a minimum, include the first four alpha numeric characters
of the ICD-10-CM medical diagnosis code, sometimes referred to as the category
and the etiology (ex. M 16.5);
(b) For dentists licensed pursuant to Chapter 4715. of the
Revised Code, the "Code on Dental Procedures and Nomenclature" (CDT
code), as published by the American dental association, of the dental treatment
requiring the controlled substance prescription.
(C) Drug distributors and terminal
distributors pursuant to paragraphs (C) and (D) of rule 4729:8-3-01 of the
Administrative Code that sell at wholesale drugs listed in Chapter 4729:8-2 of
the Administrative Code shall report the following information to the board of
pharmacy in accordance with rule 4729:8-3-03 of the Administrative
Code:
(1) Drug distributor or
terminal distributor drug enforcement administration registration number. If
not applicable, then another mutually acceptable identifier;
(2) Purchaser's drug
enforcement administration registration number. If not applicable, then another
mutually acceptable identifier;
(3) National drug code
number of the drug sold;
(4) Quantity of the drug
sold;
(5) Date of sale;
and
(6) Transaction
identifier or invoice number.
(D) Drug distributors shall report
suspicious orders and customer information pursuant to rule 4729:6-3-05 of the
Administrative Code to the drug database established in section 4729.75 of the
Revised Code.
